-
The FDA has announced a recall of 13 Fr. Trialysis Catheter with Alphacurve
Monday, November 25, 2019
The FDA has announced a recall of 13 Fr. Trialysis Catheter with Alphacurve. Catalog No. 5653150 UDI 00801741066023 Power-Trialysis Short-Term Alphacurve Dialysis Catheter with a third internal lumen for IV therapy, power injection of contrast media, and central venous pressure monitoring, because...
Read More
-
Precision Dose Inc. Issues Voluntary Nationwide Recall of Ranitidine Oral Solution
Friday, November 22, 2019
Precision Dose Inc. is voluntarily recalling 5 lots of Ranitidine Oral Solution, USP 150 mg/10 mL to the consumer level. Ranitidine Oral Solution, USP 150 mg/10 mL, is being recalled because of potential N-Nitrosodimethylamine (NDMA) amounts above levels established by the FDA. This recall is being...
Read More
-
Amneal Pharmaceuticals, LLC. Issues Voluntary Nationwide Recall of Ranitidine
Wednesday, November 13, 2019
Amneal Pharmaceuticals, LLC. Bridgewater, New Jersey is voluntarily recalling Ranitidine Tablets, 150 mg and 300 mg, and Ranitidine Syrup (Ranitidine Oral Solution, USP), 15 mg/mL to the consumer level. A listing of the recalled lots is identified below.
Read More
-
American Health Packaging Issues Voluntary Nationwide Recall of Ranitidine Syrup
Tuesday, November 12, 2019
American Health Packaging is voluntarily recalling eight lots of Ranitidine Syrup (Ranitidine Oral Solution USP) 150 mg/10 mL Liquid Unit Dose Cups to the consumer level due to the detection of trace amounts of an unexpected impurity found in the finished drug product. The impurity detected in the...
Read More
-
Aurobindo Pharma USA, Inc. Initiates Voluntary Nationwide Consumer Level Recall of 38 Lots of Ranitidine
Friday, November 8, 2019
Aurobindo Pharma USA, Inc. is conducting a voluntary recall of 1 lot of Ranitidine Tablets 150mg to the retail level and 37 lots of Ranitidine Capsules 150mg, Ranitidine Capsules 300mg and Ranitidine Syrup 15mg/mL to the consumer level due to the detection of NDMA (Nitrosodimethylamine) Impurity in...
Read More
-
Medtronic Recalls MiniMed Insulin Pumps for Potential Cybersecurity Risks
Wednesday, November 6, 2019
Medtronic is recalling the specified insulin pumps due to potential cybersecurity risks. An unauthorized person (someone other than a patient, patient caregiver, or health care provider) could potentially record and replay the wireless communication between the remote and the MiniMed insulin pump....
Read More
